Jubilant Ingrevia Board Meeting Date
Jubilant Ingrevia scheduled a board meeting for July 22, 2026. The board will consider standalone and consolidated financial results for the quarter ended June 30, 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
50 announcements with these filters
Jubilant Ingrevia scheduled a board meeting for July 22, 2026. The board will consider standalone and consolidated financial results for the quarter ended June 30, 2026.
Jubilant Ingrevia received a favourable tax order setting aside a ₹0.72 Crore demand and penalty. The ruling eliminates a contingent liability from the company's books.
Jubilant Ingrevia reported highest quarterly revenue and EBITDA in 14 quarters for Q4 FY26, driven by 10% volume growth and specialty chemical momentum.
Jubilant Ingrevia reported record quarterly revenue and EBITDA in Q4FY26, driven by specialty chemicals volume growth and effective handling of Middle East disruptions.
Jubilant Ingrevia Limited appointed M/s. J.K. Kabra and Co. as Cost Auditors for a 12-month term. This routine regulatory appointment ensures statutory costing compliance and governance.
Jubilant Ingrevia Limited appointed M/s. J.K. Kabra and Co. as Cost Auditors for a 12-month term. This ensures regulatory compliance and provides specialized oversight of costing systems.
Jubilant Ingrevia reported FY26 revenue of ₹4,388 Crore with 9% EBITDA growth. The firm highlights resilient demand and strategic growth through its Pinnacle journey initiatives.
Jubilant Ingrevia recommended a 250% final dividend (Rs. 2.50 per share) for FY 2025-26. July 24, 2026 is the fixed record date for payment.
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,179 Cr (+12.1% YoY) and net profit of ₹86.4 Cr (+16.8% YoY) for Q4 FY26.
Jubilant Ingrevia Limited reported consolidated annual revenue of ₹4,388.07 Crore with a net profit of ₹277.91 Crore. The Board recommended a final dividend of ₹2.5 per share.
Jubilant Ingrevia received a ₹19.87 Crore income tax assessment order for FY 2022-23. The company plans to appeal and anticipates no material adverse financial impact.
Jubilant Ingrevia Limited received an appeal order confirming a GST demand and penalty totaling approximately ₹2.04 Crore for FY 2017-18. The order relates to alleged wrong availment of transitional credit. The company intends to appeal the decision before the GSTAT and states there is no material financial impact.
Jubilant Ingrevia Limited has scheduled a board meeting for May 26, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 28, 2026.
Revenue flat as strong volume growth offset by persistent pricing pressures across segments. Management maintains optimism based on new CDMO capacity and ESG-driven cost savings.
Jubilant Ingrevia Limited has scheduled a Board Meeting for May 26, 2026. The directors will consider audited financial results for the quarter and year ended March 31, 2026, and a recommendation for a final dividend.
Jubilant Ingrevia Limited clarified to the BSE that it has no material unpublished price-sensitive information affecting its share price movement. The company confirmed compliance with SEBI Listing Regulations and assured continued timely disclosures of all price-sensitive events to the stock exchanges.
Jubilant Ingrevia Limited clarified to the NSE that there is no material unpublished price-sensitive information affecting its recent share price behavior. The company maintains its commitment to timely disclosures under SEBI Regulations.
Jubilant Ingrevia Limited granted 3,43,569 stock options under its 2021 ESOP plan, comprising performance-linked and tenure-linked grants. The options vest after FY30 financial closure and have a one-year exercise period from the date of vesting. The exercise price is fixed at the face value of Re. 1 per share.
Jubilant Ingrevia Limited submitted a compliance certificate for the quarter ended March 31, 2026. The filing confirms the processing and cancellation of physical share certificates for dematerialisation by its Registrar and Share Transfer Agent, Alankit Assignments Limited. This is a routine regulatory disclosure.
Jubilant Ingrevia Limited announced the results of its postal ballot, where shareholders approved the re-appointment of Mrs. Ameeta Chatterjee as an Independent Director for a second five-year term. The resolution was passed with a 97.95% majority. The voting process concluded on April 4, 2026.